Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proof of Concept for Real-time Multicentric Monitoring of Minimal Residual Disease (MRD) by PET and Circulating Tumor DNA (ctDNA) in Aggressive B-Cell Lymphomas

NCT07514715 is registered in ClinicalTrials.gov with The Lymphoma Academic Research Organisation as lead sponsor.

NCT NCT07514715
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07514715 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proof of Concept for Real-time Multicentric Monitoring of Minimal Residual Disease (MRD) by PET and Circulating Tumor DNA (ctDNA) in Aggressive B-Cell Lymphomas
Lead sponsor
The Lymphoma Academic Research Organisation
Phase
Observational
Overall status
Not yet recruiting
Start date
June 30, 2026
Completion date
October 1, 2028
Enrollment
129 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

aggressive b-cell lymphomas